Pharmacogenetics of response to antipsychotics in patients with schizophrenia

MJ Arranz, M Rivera, JC Munro - CNS drugs, 2011 - Springer
This review presents the findings of pharmacogenetic studies exploring the influence of
gene variants on antipsychotic treatment response, in terms of both symptom improvement …

Toward understanding genetic risk for differential antipsychotic response in individuals with schizophrenia

MJ Arranz, JC Munro - Expert Review of Clinical Pharmacology, 2011 - Taylor & Francis
Antipsychotic treatment response is highly heterogeneous and unpredictable in terms of
both efficacy and side effects. A combination of factors influences treatment outcome …

Analysis of efficacy and side effects in CATIE demonstrates drug response subgroups and potential for personalized medicine

SL Clark, DE Adkins, EJCG van den Oord - Schizophrenia research, 2011 - Elsevier
OBJECTIVE: This study aims to improve understanding of antipsychotic non/response and
assess the potential for personalized schizophrenia treatment. METHODS: We used data …

Pharmacogenomics of cardiovascular drugs and adverse effects in pediatrics

H Visscher, U Amstutz, J Sistonen… - Journal of …, 2011 - journals.lww.com
Individual response to medication is highly variable. For many drugs, a substantial
proportion of patients show suboptimal response at standard doses, whereas others …

Systematic review of the Genomewide Association Studies (GWAS) in schizophrenia

A Valiente, A Lafuente, M Bernardo - Revista de Psiquiatría y Salud Mental …, 2011 - Elsevier
Introduction Heritability in schizophrenia can reach up to 80% and the risk in families is 5–10
times higher than in the general population. The large contribution of genetics in this …

Statistical issues and approaches in endophenotype research

PC Sham, SS Cherny, MH Hall - Chinese Science Bulletin, 2011 - Springer
The endophenotype concept was initially proposed to enhance the power of genetic studies
of complex disorders. It is closely related to the genetic component in a liability-threshold …

Revisión sistemática de los Genomewide Association Studies (GWAS) en esquizofrenia

A Valiente, A Lafuente, M Bernardo - Revista de Psiquiatría y Salud Mental, 2011 - Elsevier
Introducción La heredabilidad en la esquizofrenia llega hasta el 80% y el riesgo en
familiares es 5-10 veces mayor que en la población general. La gran contribución genética …

[引用][C] Strategies, strengths and limitations in pharmacogenetic studies of antipsychotics

A Lafuente - Revista de psiquiatria y salud mental (English Edition), 2011 - infona.pl
Strategies, strengths and limitations in pharmacogenetic studies of antipsychotics × Close
The Infona portal uses cookies, ie strings of text saved by a browser on the user's device. The …

[引用][C] Estrategias, fortalezas y limitaciones en estudios de Farmacogenética con antipsicóticos

A Lafuente - Revista de psiquiatría y salud mental, 2011 - dialnet.unirioja.es

[引用][C] Pharmacogenomics of Alzheimer's disease

R Cacabelos - Metabolomics, 2011